Mereo BioPharma Group Hits New 1-Year Low - Should You Sell - MarketBeat
| 0P0001PGKH | 378.59 1.11 0.29% |
Slightly above 53% of Sanlam Global's investor base is interested to short. The analysis of overall sentiment of trading Sanlam Global Artificial fund suggests that many investors are impartial at this time. Sanlam Global's investing sentiment overview a quick insight into current market opportunities from investing in Sanlam Global Artificial. Many technical investors use Sanlam Global Artificial fund news signals to limit their universe of possible portfolio assets and to time the market correctly.
Sanlam |
Mereo BioPharma Group Hits New 1-Year Low - Should You Sell MarketBeat
Read at news.google.com
 |
Sanlam Global Fundamental Analysis
We analyze Sanlam Global's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sanlam Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sanlam Global based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Sanlam Global is rated below average in probability of bankruptcy among similar funds. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Sanlam Global Artificial Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sanlam Global fund to make a market-neutral strategy. Peer analysis of Sanlam Global could also be used in its relative valuation, which is a method of valuing Sanlam Global by comparing valuation metrics with similar companies.
Peers
Sanlam Global Related Equities
| 0P0001PY0U | Amundi MSCI | 1.45 | ||||
| 0AAU | Surgical Science | 0.45 | ||||
| 0P0001PGKH | Sanlam Global | 0.29 | ||||
| IGSU | IShares Dow | 0.22 | ||||
| FVUB | Franklin FTSE | 0.18 | ||||
| 0R8Q | Coor Service | 0.24 | ||||
| SAN | SANTANDER | 0.26 | ||||
| 0P0000XSLC | Polar Capital | 0.70 | ||||
| 0A9G | Mereo BioPharma | 10.96 |
Other Information on Investing in Sanlam Fund
Sanlam Global financial ratios help investors to determine whether Sanlam Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sanlam with respect to the benefits of owning Sanlam Global security.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |